Show simple item record

dc.contributor.authorMuhammad, Fakhar-E-Alam
dc.contributor.authorSyed Muhammad Usman, Ali
dc.contributor.authorZafar Hussain, Ibupoto
dc.contributor.authorKimleang, Khun
dc.contributor.authorMuhammad, Atif
dc.contributor.authorMohammad, Kashif
dc.contributor.authorLoong, Foo Kai
dc.contributor.authorUda, Hashim, Prof. Dr.
dc.contributor.authorWillander, Magnus
dc.date.accessioned2012-04-16T04:49:11Z
dc.date.available2012-04-16T04:49:11Z
dc.date.issued2012-05
dc.identifier.citationLasers in Medical Science, vol. 27(3), 2012, pages 607-614en_US
dc.identifier.issn0268-8921
dc.identifier.urihttp://www.springerlink.com/content/t04mtw4h12867142/
dc.identifier.urihttp://dspace.unimap.edu.my/123456789/18835
dc.descriptionLink to publisher's homepage at http://www.springerlink.com/en_US
dc.description.abstractIn the present study, we demonstrated the use of nanoporous zinc oxide (ZnO NPs) in photodynamic therapy. The ZnO NPs structure possesses a high surface to volume ratio due to its porosity and ZnO NPs can be used as an efficient photosensitizer carrier system. We were able to grow ZnO NPs on the tip of borosilicate glass capillaries (0.5 μm diameter) and conjugated this with Photofrin for efficient intracellular drug delivery. The ZnO NPs on the capillary tip could be excited intracellularly with 240 nm UV light, and the resultant 625 nm red light emitted in the presence of Photofrin activated a chemical reaction that produced reactive oxygen species (ROS). The procedure was tested in A-549 cells and led to cell death within a few minutes. The morphological changes in necrosed cells were examined by microscopy. The viability of control and treated A-549 cells with the optimum dose of UV/visible light was assessed using the MTT assay, and ROS were detected using a fluorescence microscopy procedure.en_US
dc.language.isoenen_US
dc.publisherSpringer-Verlag London Ltd.en_US
dc.subjectCell viabilityen_US
dc.subjectLung cancer (A-549) cellsen_US
dc.subjectMTT assay Photofrinen_US
dc.subjectNanoporous zinc oxide (ZnO NPs)en_US
dc.subjectPhotodynamic therapy (PDT)en_US
dc.subjectReactive oxygen species (ROS)en_US
dc.titleSensitivity of A-549 human lung cancer cells to nanoporous zinc oxide conjugated with Photofrinen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record